![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cellu Tissue Holdings USD0.01 | NYSE:CLU | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.99 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 6, 2010
Cellu Tissue Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-34606 | 06-1346495 | ||
(State or other jurisdiction | (Commission File Number) | (IRS Employer | ||
of incorporation) | Identification No.) |
1855 Lockeway Drive
Suite 501 Alpharetta, Georgia |
30004 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code (678) 393-2651
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 | RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
Cellu Tissue Holdings, Inc. issued a press release today announcing results for the second quarter of fiscal year ended February 28, 2011. The press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
The information in this Form 8-K, including the accompanying exhibit, is being furnished hereunder and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
The following is being furnished as an exhibit to this Current Report on Form 8-K:
(d) Exhibits
99.1 Release, dated October 6, 2010, Cellu Tissue Holdings, Inc. Announces Second Quarter Fiscal 2011 Results
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cellu Tissue Holdings, Inc. | ||||||
(Registrant) | ||||||
Date: October 6, 2010 | By: |
/s/ David J. Morris |
||||
Mr. David J. Morris | ||||||
Senior Vice President, Finance and Chief Financial Officer |
3
EXHIBIT INDEX
99.1 | Release, dated October 6, 2010 Cellu Tissue Holdings, Inc. Announces Second Quarter Fiscal 2011 Results |
4
1 Year Canada Life Chart |
1 Month Canada Life Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions